Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 0 | 0 | 0 | 7,500 |
| Gross Profit | N/A | N/A | N/A | N/A | 7,500 |
| Operating Expenses | 112,328 | 109,767 | 96,336 | 94,229 | 80,238 |
| Operating Income | -112,328 | -109,767 | -96,336 | -94,229 | -72,738 |
| Other Income | 7,455 | 5,044 | 6,117 | 8,897 | 8,118 |
| Pre-tax Income | -104,873 | -104,723 | -90,219 | -85,332 | -64,620 |
| Income Tax | -2,571 | 538 | 677 | -626 | 427 |
| Net Income Continuous | -102,302 | -105,261 | -90,896 | -84,706 | -65,047 |
| Net Income | $-102,302 | $-105,261 | $-90,896 | $-84,706 | $-65,047 |
| EPS Basic Total Ops | -1.17 | -1.31 | -1.15 | -1.07 | -0.83 |
| EPS Basic Continuous Ops | -1.17 | -1.32 | -1.15 | -1.07 | -0.83 |
| EPS Diluted Total Ops | -1.17 | -1.31 | -1.15 | -1.07 | -0.83 |
| EPS Diluted Continuous Ops | -1.17 | -1.32 | -1.15 | -1.07 | -0.83 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.31 | -1.15 | -1.07 | -0.83 |
| EBITDA(a) | $-111,741 | $-109,156 | $-95,695 | $-93,597 | $-72,079 |